There are currently licensed vaccines against various serotypes of S. pneumonia (i.e., Prevnar 13, which includes Sp1) yet the structure/immunogenicity ratio is still not entirely known. This evidence concerns the gene SP1 and susceptibility to pneumonia measurement.